Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

AbstractAboutThe 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Ischemic Heart Disease

  Free Subscription


Articles published in Can J Cardiol

Retrieve available abstracts of 86 articles:
HTML format



Single Articles


    November 2025
  1. MAHAJAN K, Rana V
    Enhancing Clinical Relevance of AI-Based Risk Prediction in Acute Myocardial Infarction.
    Can J Cardiol. 2025 Nov 1:S0828-282X(25)01299-1. doi: 10.1016/j.cjca.2025.
    PubMed    


  2. PU X, Peng Y, Zhou X, Yang P, et al
    Development and Validation of a Nomogram for Predicting Intravenous Immunoglobulin-Responsive Coronary Progression in Kawasaki Disease.
    Can J Cardiol. 2025;41:2275-2287.
    PubMed     Abstract available


    October 2025
  3. ZORDOK M, Al-Azizi K, Szerlip M, Basir MB, et al
    Cardiogenic Shock in Takotsubo vs. Acute Myocardial Infarction: Insights from The National Readmission Database 2016-2022.
    Can J Cardiol. 2025 Oct 16:S0828-282X(25)01201.
    PubMed     Abstract available


  4. IZUMI A, Yau TM, Fedak PWM, Fatehi Hassanabad A, et al
    Pericardial Delivery of Stem Cells: An Emerging Frontier in Myocardial Regeneration for Ischemic Heart Disease.
    Can J Cardiol. 2025 Oct 14:S0828-282X(25)01214.
    PubMed     Abstract available


  5. SHIH AW, Schnell G, Belley-Cote E, Lett R, et al
    Canadian Cardiovascular Society and National Advisory Committee on Blood and Blood Products Joint Statement on Blood Utilization and Transfusion for Patients With Acute Coronary Syndromes.
    Can J Cardiol. 2025;41:1875-1884.
    PubMed     Abstract available


  6. WANG K, Sharir T, Hauser MT, Dorbala S, et al
    Reassessing Cardiovascular Risk in Patients With Peripheral Artery Disease Undergoing Myocardial Perfusion Imaging.
    Can J Cardiol. 2025;41:1936-1945.
    PubMed     Abstract available


  7. SCOTT M, Kyriakopoulos CP, Sheffield E, Krauspe E, et al
    Application of the Updated Cardiogenic Shock Working Group SCAI Classification for Cardiogenic Shock: A Single-Centre Analysis.
    Can J Cardiol. 2025;41:2053-2063.
    PubMed     Abstract available


    September 2025
  8. GHAFFAR MD, Javed MU
    Reassessing the Clinical Applicability of Artificial Intelligence Driven Risk Models in Acute Myocardial Infarction.
    Can J Cardiol. 2025 Sep 27:S0828-282X(25)01188.
    PubMed    


  9. CAI D, Sun T, Wei J, Deng L, et al
    Explainable Artificial Intelligence-Driven Risk Assessment for Malignant Ventricular Arrhythmia and Mortality in Acute Myocardial Infarction.
    Can J Cardiol. 2025 Sep 17:S0828-282X(25)01167.
    PubMed     Abstract available


    August 2025
  10. WONG HJ, Low CE, Yau CE, Teo YH, et al
    Optimization of Guideline-Directed Medical Therapy Prescription after First-onset Myocardial Infarction in the Very Elderly.
    Can J Cardiol. 2025 Aug 22:S0828-282X(25)01035.
    PubMed    


  11. SHI J
    Improving Guideline Therapy Assessment After First Myocardial Infarction in the Very Elderly Population.
    Can J Cardiol. 2025 Aug 11:S0828-282X(25)00659.
    PubMed    


  12. HAYES SN, Gulati R
    Navigating Therapeutic Ambiguity: Thrombolysis in Spontaneous Coronary Artery Dissection Presenting As ST-Segment Elevation Myocardial Infarction.
    Can J Cardiol. 2025 Aug 4:S0828-282X(25)00648-8. doi: 10.1016/j.cjca.2025.
    PubMed    


  13. SHENG Z, Che W, An S, Zhang Z, et al
    Assessing Coronary Microvascular Dysfunction Using Angiographic Frame Count in Patients With Angina and Nonobstructive Coronary Arteries.
    Can J Cardiol. 2025;41:1446-1455.
    PubMed     Abstract available


  14. POLETTI E, Kearney KE, Chung CJ, Elison D, et al
    Predicting Mortality and Periprocedural Adverse Events in Patients Undergoing Complex and Higher Risk Percutaneous Coronary Intervention.
    Can J Cardiol. 2025;41:1434-1442.
    PubMed     Abstract available


  15. ABDELGHANI M, Hemetsberger R, Hassan A, Abdelshafy M, et al
    Acute Coronary Syndromes after Transcatheter Aortic Valve Implantation: Incidence, Unique Mechanisms, and Outcomes.
    Can J Cardiol. 2025;41:1628-1637.
    PubMed     Abstract available


  16. GUPTA AK, Mustafiz C, Mutahar D, Zaka A, et al
    Machine Learning vs Traditional Approaches to Predict All-Cause Mortality for Acute Coronary Syndrome: A Systematic Review and Meta-analysis.
    Can J Cardiol. 2025;41:1564-1583.
    PubMed     Abstract available


    July 2025
  17. ST JOHN PD, Bourgeois-Gosselin J, Tate RB
    Initial Presentation of Ischemic Heart Disease over the Life Course of Aging Men: The Manitoba Follow Up Study.
    Can J Cardiol. 2025 Jul 18:S0828-282X(25)00632.
    PubMed    


  18. JAMHOUR-CHELH K, Jimenez-Kockar M, Fernandez-Peregrina E, Arzamendi D, et al
    Dissecting ST-elevation myocardial infarction pathophysiology through invasive physiology: Prognostic insight or actionable clinical guidance?
    Can J Cardiol. 2025 Jul 16:S0828-282X(25)00628.
    PubMed    


  19. LI J, Xie P, Hu Y, Zhou Y, et al
    Predictive Value of Combining Angio-Based Index of Microcirculatory Resistance and Fractional Flow Reserve in Patients with STEMI.
    Can J Cardiol. 2025;41:1363-1371.
    PubMed     Abstract available


    June 2025
  20. BROPHY JM
    The trials of interpreting clinical trials - A Bayesian perspective on colchicine following an acute coronary syndrome.
    Can J Cardiol. 2025 Jun 19:S0828-282X(25)00391.
    PubMed     Abstract available


  21. SKALIDIS I, Akodad M, Neylon A, Garot J, et al
    Angiography-Derived Microvascular Dysfunction Evaluation in Patients with Diabetes and ST-Segment Elevation Myocardial Infarction.
    Can J Cardiol. 2025 Jun 11:S0828-282X(25)00387.
    PubMed    


  22. BOUDREAU R, Chih S, Le May M, Di Santo P, et al
    Balancing Costs and Benefits: A Less DanGerous Protocol for Myocardial Infarction Complicated by Cardiogenic Shock.
    Can J Cardiol. 2025 Jun 10:S0828-282X(25)00383.
    PubMed    


    May 2025
  23. WU Y, Liu J, Du X, Li M, et al
    Prognostic Value of Angiography-derived Index of Microcirculatory Resistance in Patients with diabetes and ST-Segment Elevation Myocardial Infarction.
    Can J Cardiol. 2025 May 9:S0828-282X(25)00334-4. doi: 10.1016/j.cjca.2025.
    PubMed     Abstract available


  24. UZUN F, Guner A, Serin E, Alizade E, et al
    Mini-crush or Nano-crush Stenting Technique for Complex Coronary Bifurcation Lesions: the Multicenter MINANO Registry.
    Can J Cardiol. 2025;41:878-887.
    PubMed     Abstract available


  25. DERIMAY F, Mercier A, Aminian A, Maillard L, et al
    Benefit of Systematic "Jailed Wire" Technique for Bifurcation Provisional Stenting. A CABRIOLET Substudy.
    Can J Cardiol. 2025;41:871-877.
    PubMed     Abstract available


    April 2025
  26. MATTIUZZI C, Lippi G
    Mortality Risk of Acute Myocardial Infarction and Acute Myocarditis in COVID-19 and Influenza: A U.S. Nationwide Analysis Using Death Certificates.
    Can J Cardiol. 2025 Apr 29:S0828-282X(25)00327.
    PubMed    


  27. GIN K, Wong GC, Greene DN
    Advancing risk stratification with a troponin-based universal algorithm for non-ST elevation myocardial infarction: Are we ready for a C change?
    Can J Cardiol. 2025 Apr 4:S0828-282X(25)00242-9. doi: 10.1016/j.cjca.2025.
    PubMed    


  28. SACCHI S, Venuti A, Gobbi FM, Gambaro A, et al
    Clinical Prediction Score for Successful Liberation from Temporary Mechanical Circulatory Support in Cardiogenic Shock Patients.
    Can J Cardiol. 2025;41:730-739.
    PubMed     Abstract available


  29. SO DYF, Boudreau R, Chih S
    The Role of a Cardiogenic Shock Team in Decision Making Surrounding Mechanical Circulatory Support.
    Can J Cardiol. 2025;41:682-690.
    PubMed     Abstract available


  30. HUNG A, Slawnych M, McGuinty C
    Enhancing Care in Cardiogenic Shock: Role of Palliative Care in Acute Cardiogenic Shock Through Destination Therapy.
    Can J Cardiol. 2025;41:669-681.
    PubMed     Abstract available


  31. BARKER M, van Diepen S, Granger CB, Wong GC, et al
    Differences in Care and Outcomes in Cardiogenic Shock in Cardiac Intensive Care Units in the United States and Canada: CCCTN Registry Insights.
    Can J Cardiol. 2025;41:718-727.
    PubMed     Abstract available


  32. BRAHMBHATT DH, Kalra S, Luk A, Billia F, et al
    From Escalate to Elevate: A New Paradigm for Comprehensive Cardiogenic Shock Management.
    Can J Cardiol. 2025;41:630-644.
    PubMed     Abstract available


  33. CHILLETTI R, Ihle J, Butt W
    Mechanical Circulatory Support for Septic Shock in Children and Adults: Different But Similar.
    Can J Cardiol. 2025;41:605-612.
    PubMed     Abstract available


  34. YUEN T, Senaratne JM
    Definition, Classification, and Management of Primary Noncardiac Causes of Cardiogenic Shock.
    Can J Cardiol. 2025;41:587-604.
    PubMed     Abstract available


    March 2025
  35. MARZOLINI S, Oh P, Peterman JE, Wallace P, et al
    Sex Differences and Correlates of the Utility of the Cardiopulmonary Exercise Test for Prescribing Exercise at Entry to Cardiac Rehabilitation.
    Can J Cardiol. 2025;41:481-490.
    PubMed     Abstract available


    February 2025
  36. THIESSEN N, Pickering JW, Kellner C, Haller PM, et al
    A common algorithm for cardiac troponin to rule-out and rule-in acute myocardial infarction.
    Can J Cardiol. 2025 Feb 26:S0828-282X(25)00173.
    PubMed     Abstract available


  37. BOUDREAU R, Le May M, Malhotra N, Clifford C, et al
    Evaluating Volume and Resource Needs for Implementing an ST-Elevation Myocardial Infarction Shock Protocol.
    Can J Cardiol. 2025 Feb 6:S0828-282X(25)00107-2. doi: 10.1016/j.cjca.2025.
    PubMed    


  38. WANG J, Wang P, Liu H, Zhao Y, et al
    Impact of High-Sensitivity Cardiac Troponin I Elevation After On- and Off-Pump Coronary Artery Bypass Grafting on Long-Term Prognosis.
    Can J Cardiol. 2025;41:294-305.
    PubMed     Abstract available


    January 2025
  39. WONG HJ, Toh KZX, Low CE, Yau CE, et al
    Guideline-Directed Medical Therapy in Nonagenarians and Centenarians (>/=90 Years Old) After First-Onset Myocardial Infarction - A National Registry Study.
    Can J Cardiol. 2025 Jan 31:S0828-282X(25)00101.
    PubMed     Abstract available


  40. RANDHAWA VK, Baran DA, Kanwar MK, Hernandez-Montfort JA, et al
    The comparative epidemiology, pathophysiology and management of cardiogenic shock associated with acute myocardial infarction and advanced heart failure.
    Can J Cardiol. 2025 Jan 30:S0828-282X(25)00097.
    PubMed     Abstract available


  41. LUK A, Barker M, Billia P, Fordyce CB, et al
    ECLS-SHOCK and DanGer Shock: Implications for optimal temporary mechanical circulatory support use for cardiogenic shock due to acute myocardial infarction.
    Can J Cardiol. 2025 Jan 15:S0828-282X(25)00014.
    PubMed     Abstract available


  42. CHEN H, Adam A, Oudit GY
    Apelin analog reduces the burden of post myocardial infarction adverse remodeling: a new therapeutic approach for ischemic heart disease.
    Can J Cardiol. 2025 Jan 7:S0828-282X(25)00003-0. doi: 10.1016/j.cjca.2025.
    PubMed    


  43. LAVERDURE M, Clifford CR, Barry Q, Knoll W, et al
    Can the Present Canadian Health Care System Provide Evidence-Based Pharmaceutical Care? Consideration of Two Important Cardiovascular Clinical Contexts.
    Can J Cardiol. 2025;41:60-67.
    PubMed     Abstract available


  44. ZENG M, Chu M, Xu L, Yi B, et al
    Value of Combined Optical Coherence Tomography and Optical Flow Ratio Measurements After Percutaneous Coronary Intervention.
    Can J Cardiol. 2025;41:1-8.
    PubMed     Abstract available


    December 2024
  45. GIRAULT-SOTIAS PE, Deloux R, De Mota N, Riche S, et al
    The metabolically resistant apelin-17 analog LIT01-196 reduces cardiac dysfunction and remodeling in heart failure after myocardial infarction.
    Can J Cardiol. 2024 Dec 12:S0828-282X(24)01258.
    PubMed     Abstract available


  46. MISTRY N, Mazer CD, Sivaswamy A, Haldenby O, et al
    Transfusion in Anemic Patients With Acute Coronary Syndromes: A Population-Based Cohort Study.
    Can J Cardiol. 2024;40:2515-2524.
    PubMed     Abstract available


    November 2024
  47. LONN A, Niyonsenga T, Carroll SJ, Bauman A, et al
    Physical activity and sedentary behaviour thresholds for secondary prevention of coronary heart disease: morbidity survival tree analysis.
    Can J Cardiol. 2024 Nov 29:S0828-282X(24)01230.
    PubMed     Abstract available


  48. HIASA Y, Higaki A, Kamei Y, Nishikawa T, et al
    Impact of Aromatase Inhibitors Treatment Duration on Coronary Artery Calcification in Postoperative Patients With Breast Cancer.
    Can J Cardiol. 2024;40:2224-2230.
    PubMed     Abstract available


  49. TAN MC, Dinh D, Gayed D, Liang D, et al
    Associations Between Dual Antiplatelet Therapy Score and Long-Term Mortality After Percutaneous Coronary Intervention: Analysis of More Than 27,000 Patients.
    Can J Cardiol. 2024;40:2045-2053.
    PubMed     Abstract available


  50. EIKELBOOM JW, Yi Q, McIntyre WF, Bosch J, et al
    Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic Approaches.
    Can J Cardiol. 2024;40:2171-2179.
    PubMed     Abstract available


  51. NARUI S, Yamamoto MH, Mori H, Amemiya K, et al
    Mechanism of Stent Failure in Patients With Eruptive Calcified Nodule Treated With Rotational Atherectomy.
    Can J Cardiol. 2024;40:1998-2007.
    PubMed     Abstract available


  52. SIBBALD M, Cioffi GM, Shenouda M, McGrath B, et al
    Intravascular Imaging in the Diagnosis and Management of Patients With Suspected Intracoronary Pathologies: A CJC White Paper.
    Can J Cardiol. 2024;40:1977-1994.
    PubMed     Abstract available


  53. DOAN VD, Zheng C, Onwuzurike J, Chen A, et al
    Prognostic Value of Stress Myocardial Perfusion Imaging Across the Spectrum of Cardiovascular Risk.
    Can J Cardiol. 2024;40:2205-2214.
    PubMed     Abstract available


  54. SHAVADIA JS, Okpalauwaekwe U, Kim M, Orvold J, et al
    Contemporary Outcomes of Acute Coronary Syndromes in Indigenous Compared With Non-Indigenous Patients: A Northern Saskatchewan Perspective.
    Can J Cardiol. 2024;40:2094-2101.
    PubMed     Abstract available


    October 2024
  55. ZHAO C, Lu P, Wang J, Liu Y, et al
    A Novel Therapy for the Failing Right Ventricle in Acute Myocardial Infarction: The First Reported Cases.
    Can J Cardiol. 2024 Oct 29:S0828-282X(24)01040.
    PubMed     Abstract available


    September 2024
  56. AZZALINI L
    A New Kid on the Block in the Rapidly Evolving Landscape of Intravascular Lithotripsy: Novel Technologies for Challenging Calcified Coronary Lesions.
    Can J Cardiol. 2024;40:1668-1670.
    PubMed    


  57. WANG Q, Ma W, Zhang D, Zhang W, et al
    Effectiveness and Safety of a Novel Intravascular Lithotripsy System for Severe Coronary Calcification: The CALCI-CRACK Trial.
    Can J Cardiol. 2024;40:1657-1667.
    PubMed     Abstract available


  58. AGUILAR M
    My Big Fat Coronary Bypass Surgery: Sex, Obesity, and Postoperative Atrial Fibrillation.
    Can J Cardiol. 2024;40:1576-1579.
    PubMed    


  59. DZAVIK V
    A Left Main Bifurcation Risk Score: Can It Safely Guide Our Choice of Bifurcation Stenting Technique?
    Can J Cardiol. 2024;40:1632-1634.
    PubMed    


  60. HE J, Cai Z, Wang HY, Zhang R, et al
    A New Scoring System Predicting Side-Branch Occlusion in Patients Undergoing Left Main Bifurcation Intervention: The LM V-RESOLVE Score.
    Can J Cardiol. 2024;40:1619-1631.
    PubMed     Abstract available


    August 2024
  61. SMILOWITZ NR
    Unresolved Controversies in Revascularization for Cardiogenic Shock with Acute Myocardial Infarction.
    Can J Cardiol. 2024 Aug 30:S0828-282X(24)00934.
    PubMed    


  62. MARQUIS-GRAVEL G, Bhatia S, Brown V, Goodman SG, et al
    Care Gaps and System Issues With Delivering Cardiovascular Risk Reduction and Lipid-Lowering Therapy in Secondary Prevention.
    Can J Cardiol. 2024;40.
    PubMed     Abstract available


    July 2024
  63. ROSTON TM, Aghanya V, Savu A, Fordyce CB, et al
    Premature Acute Myocardial Infarction Treated with Invasive Revascularization: Comparing STEMI to NSTEMI in a Population-Based Study of Young Patients.
    Can J Cardiol. 2024 Jul 9:S0828-282X(24)00521-X. doi: 10.1016/j.cjca.2024.
    PubMed     Abstract available


  64. RIVARD A
    Real-World Treatment of In-Stent Restenosis: The Return of the Balloon.
    Can J Cardiol. 2024;40:1258-1260.
    PubMed    


  65. AZZALINI L, Johal GS
    Complex and High-Risk Percutaneous Coronary Intervention at Centers With No Surgical Back-Up: Are We Ready for Prime Time?
    Can J Cardiol. 2024;40:1247-1249.
    PubMed    


  66. DOOLUB G, Ly HQ, Marquis-Gravel G
    Should Rotational Atherectomy Be Used More Often in STEMI to Treat Calcified Culprit Lesions?
    Can J Cardiol. 2024;40:1234-1236.
    PubMed    


  67. AZZALINI L, Kearney KE, Lombardi WL
    Intravascular Lithotripsy-Facilitated Balloon-Assisted Subintimal Entry for Chronic Total Occlusion Percutaneous Coronary Intervention.
    Can J Cardiol. 2024;40:1261-1263.
    PubMed    


  68. SHAMKHANI W, Rashid M, Moledina S, Ludman P, et al
    Complex High-Risk Percutaneous Coronary Intervention Types, Trends, and Outcomes in Nonsurgical Centres.
    Can J Cardiol. 2024;40:1237-1246.
    PubMed     Abstract available


  69. KHEIFETS M, Rahat O, Bental T, Levi A, et al
    Outcomes of Drug-Eluting Balloons for In-Stent Restenosis: Large Cohort Analysis and Single-Center Clinical Experience.
    Can J Cardiol. 2024;40:1250-1257.
    PubMed     Abstract available


    June 2024
  70. PACHECO C, Coutinho T, Bastiany A, Beanlands R, et al
    Canadian Cardiovascular Society/Canadian Women's Heart Health Alliance Clinical Practice Update on Myocardial Infarction With No Obstructive Coronary Artery Disease (MINOCA).
    Can J Cardiol. 2024;40:953-968.
    PubMed     Abstract available


  71. MOHAMED MO, Ghosh AK, Banerjee A, Mamas M, et al
    Socioeconomic and Ethnic Disparities in the Process of Care and Outcomes Among Cancer Patients With Acute Coronary Syndrome.
    Can J Cardiol. 2024;40:1146-1153.
    PubMed     Abstract available


  72. LUU JM, Bairey Merz CN, Wei J
    Reply to Pendyal-Long-term Adverse Outcomes in Black Women With Obstructive Coronary Artery Disease: A Study of the Women's Ischemia Syndrome Evaluation (WISE) Cohort.
    Can J Cardiol. 2024;40:1177.
    PubMed    


    May 2024
  73. LEE G, Malik A, Vervoort D, Tam DY, et al
    Revascularization in Left Ventricular Systolic Dysfunction: A Meta-Analysis of Kaplan-Meier Reconstructed Individual Patient Data.
    Can J Cardiol. 2024 May 30:S0828-282X(24)00414.
    PubMed     Abstract available


    April 2024
  74. ROBERT YAO RJ, Fordyce CB
    Optimal transfusion threshold for anemic patients presenting with myocardial infarction and heart failure: dream or REALITY?
    Can J Cardiol. 2024 Apr 9:S0828-282X(24)00299-X. doi: 10.1016/j.cjca.2024.
    PubMed    


  75. COURTNEY BK
    Very Late Stent Thrombosis in Japan: A Look Into the Future?
    Can J Cardiol. 2024;40:705-706.
    PubMed    


  76. REA ABBAC, Mihajlovic V, Vishram-Nielsen JKK, Brahmbhatt DH, et al
    Pulmonary Artery Catheter Usage and Impact on Mortality in Patients With Cardiogenic Shock: Results From a Canadian Single-Centre Registry.
    Can J Cardiol. 2024;40:664-673.
    PubMed     Abstract available


  77. MORI H, Sekimoto T, Arai T, Sakai R, et al
    Mechanisms of Very Late Stent Thrombosis in Japanese Patients as Assessed by Optical Coherence Tomography.
    Can J Cardiol. 2024;40:696-704.
    PubMed     Abstract available


  78. DESSUREAULT A, Massie E, Fish D, Parent MC, et al
    Cardiomyopathy and Cardiogenic Shock Caused by Juvenile Hemochromatosis Improving With Guideline-Directed Medical Therapy Despite High Ferritin Levels.
    Can J Cardiol. 2024;40:662-663.
    PubMed    


  79. AMJAD M
    High-Sensitivity Cardiac Troponin I Thresholds to Identify Myocardial Injury After Noncardiac Surgery.
    Can J Cardiol. 2024;40:734.
    PubMed    


  80. GUERRA PG, Simpson CS, Van Spall HGC, Asgar AW, et al
    Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive.
    Can J Cardiol. 2024;40:500-523.
    PubMed     Abstract available


    March 2024
  81. AKIOYAMEN LE, Ko DT, Cram P, Landon BE, et al
    Approaches to comparing the impact of socioeconomic disadvantage on acute myocardial infarction care within and across countries: a Scoping review.
    Can J Cardiol. 2024 Mar 26:S0828-282X(24)00274.
    PubMed     Abstract available


  82. SAADA M, Lavi S
    Angiography-Derived Index of Microvascular Resistance: A New Frontier in the Management of Patients With Coronary Artery Disease.
    Can J Cardiol. 2024;40:444-446.
    PubMed    


  83. CHEN L, Sang C, Wu Y, Chen W, et al
    Coronary Angiography-Derived Index of Microcirculatory Resistance Associated With New-Onset Atrial Fibrillation in Patients With STEMI.
    Can J Cardiol. 2024;40:434-443.
    PubMed     Abstract available


  84. SHOWKATHALI R, Yalamanchi RP, Kumar AM, Cs V, et al
    Isolated Giant Right Coronary Aneurysm Associated With IgG4-Related Disease.
    Can J Cardiol. 2024;40:447-449.
    PubMed    


  85. TSUNETA S, Suno K, Fujieda Y, Watanabe M, et al
    Accumulation of Technetium-99m Tetrofosmin on Myocardial Perfusion Scintigraphy in a Patient With Immunoglobulin G4-Related Coronary Periarteritis.
    Can J Cardiol. 2024;40:450-451.
    PubMed    


    February 2024
  86. DUCROCQ G, Cachanado M, Simon T, Puymirat E, et al
    Restrictive vs Liberal Blood Transfusions for Patients with Acute Myocardial Infarction and Anaemia by Heart Failure Status: An RCT Subgroup Analysis.
    Can J Cardiol. 2024 Feb 24:S0828-282X(24)00179.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.